BII
BMRN icon

Baring International Investment’s BioMarin Pharmaceuticals BMRN Stock Holding History

Baring International Investment’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$4.23M Sell
68,063
-35,626
-34% -$2.15M 0.27% 86
2014
Q1 		$7.07M Buy
+103,689
New +$7.64M 0.42% 76

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Baring International Investment's BMRN Position: Q2 2014 in Review

Baring International Investment reduced its BioMarin Pharmaceuticals (BMRN) stake by 34% in Q2 2014, selling an estimated $2.15M and leaving 68,063 shares worth $4.23M. The position accounts for 0.27% of the portfolio, ranked #86.

Baring International Investment first reported a position in BMRN in Q1 2014 and has held it in 2 quarters since. The position peaked at $7.07M in Q1 2014. 321 funds tracked by Wall St. Rank hold BMRN as of Q2 2014.

  • Baring International Investment held 68,063 shares of BioMarin Pharmaceuticals worth $4.23M as of Q2 2014.
  • Baring International Investment sold 35,626 BioMarin Pharmaceuticals shares in Q2 2014, an estimated $2.15M.
  • BioMarin Pharmaceuticals made up 0.27% of Baring International Investment's portfolio in Q2 2014, its #86 holding.
  • Baring International Investment first reported a position in BioMarin Pharmaceuticals in Q1 2014 and has held it in 2 quarters since.
  • Baring International Investment's BioMarin Pharmaceuticals position peaked at $7.07M in Q1 2014.
  • 321 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2014.

Based on Baring International Investment's 13F filing for Q2 2014, filed 21 Jul 2014.